focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
There is a lot in said litigation which would not have been controlled by TRX if, as appears clear; it was insured. The insurer via subrogation would have stepped into the company's shoes. The cost to TRX would have been any excess on its policy. The Insurer would have paid any Award or Settlement sum.
As you say it is in the past.
The Alliance newsflash of 20th April said:
'The principal, however, does not need to be repaid if the funds (just over $1m) go towards supporting employee payroll, healthcare, rent, and utlities in the US over the next two months.'
Does anyone know the exact burn per month on these overheads?
That aside even if financing/funding were announced tomorrow the interest payable (if repayable at all) on the US Government Funding is just 1% ($10,000 pa) so no real handicap to announcing or completing refinancing / funding at any time soon.
So my position is very clear I will not be selling hoping to get back in ahead of a stampede.
GLA
So what is your point B2?
The costs were covered in the exceptional items of the 2018 accounts:
'Exceptional items: Cost relating to the settlement of a LifeNet litigation case are accounted in the exceptional items, covering a final legal payment and insurance upfront excess. There are no other costs to be incurred relating to this case."
Incidentally it looks like TRX weere insured in relation to the matter
Over 4 x buys to sells today and sp stayed squat.
I think when finances are sorted , and I suspect that will be reasonably soon thatTRX will consolidate its shares as in perhaps 10: 1. ( which means that the sp of each new share would be 10 x the value of an old share). This would assist the perception of TRX as a serious player. I think that a combination of the number of shares in issue times a sub penny price is just not attractive . For the record I would be happy to see my holding consolidated in this manner. .